EC grants EMA to DuoCort Plenadren
Pharmaceutical Business Review
DuoCort Pharma's Plenadren (hydrocortisone, modified release tablet) has received European Marketing Authorisation (EMA) by the European Commission (EC), to treat adrenal insufficiency in adults. Plenadren, an oral once daily tablet, is a dual release ...
DuoCort Pharma's Orphan Drug PlenadrenĀ® Granted European Marketing ...MarketWatch (press release)
EC Sanction of DuoCort's Plenadren Triggers ViroPharma's $33M Acquisition of ...Genetic Engineering News
DuoCort adrenal insufficiency drug OK'd in
all 17 news articles »